Cargando…

Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes

INTRODUCTION: The aim of this study was to describe appetite and glucose fluctuation in type 2 diabetes mellitus patients initiating treatment with dulaglutide combined with insulin degludec. METHODS: This retrospective study of patients identified adults starting treatment with once-weekly (QW) dul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jinxin, Hua, Fei, Jiang, Xiaohong, Zhang, Xingguang, Yang, Minxing, Wang, Long, Huang, Xiaolin, Luo, Kaiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225703/ https://www.ncbi.nlm.nih.gov/pubmed/37255975 http://dx.doi.org/10.3389/fendo.2023.1130470

Ejemplares similares

Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yang, Yunjiao, et al.
Publicado: (2022)

The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2019)

Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
por: Kim, Youngsook, et al.
Publicado: (2022)

Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns
por: Demir, Tevfik, et al.
Publicado: (2021)

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus
por: Du, Juan, et al.
Publicado: (2023)

Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
por: Kim, Hwi Seung, et al.
Publicado: (2022)

Overexpression of miR-146a Might Regulate Polarization Transitions of BV-2 Cells Induced by High Glucose and Glucose Fluctuations
por: Huang, Yinqiong, et al.
Publicado: (2019)

Insulin degludec and insulin degludec/insulin aspart in Ramadan: A single center experience
por: Kalra, Sanjay
Publicado: (2016)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
por: Zhang, Zhen-Ye, et al.
Publicado: (2019)

Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes
por: Meng, Ziyu, et al.
Publicado: (2023)

Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population
por: Liu, Hongzhong, et al.
Publicado: (2021)

Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region
por: Nosek, Leszek, et al.
Publicado: (2014)

Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Edina, Brenda C, et al.
Publicado: (2022)

A Case of Dulaglutide-Induced Vaginal Bleed
por: Vaccaro, Christopher J, et al.
Publicado: (2023)

Life Under Hypoxia Lowers Blood Glucose Independently of Effects on Appetite and Body Weight in Mice
por: Abu Eid, Sameer, et al.
Publicado: (2018)

Case Report of Acute Pancreatitis Associated With Combination Treatment of Dulaglutide and Glipizide
por: Babajide, Oyedotun, et al.
Publicado: (2022)

Degludec insulin: A novel basal insulin
por: Kalra, Sanjay, et al.
Publicado: (2011)

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2017)

Glutamate and GABA in Appetite Regulation
por: Delgado, Teresa C.
Publicado: (2013)

In-hospital experience with insulin degludec (IDeg)
por: Bulisani, Maria Gabriela Pedigoni, et al.
Publicado: (2015)

Pediatric diabetes: Potential for insulin degludec
por: Kalra, Sanjay, et al.
Publicado: (2014)

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report
por: Dardano, Angela, et al.
Publicado: (2022)

Neuroendocrine regulation of appetitive ingestive behavior
por: Keen-Rhinehart, Erin, et al.
Publicado: (2013)

CART in the regulation of appetite and energy homeostasis
por: Lau, Jackie, et al.
Publicado: (2014)

Appetite-Controlling Endocrine Systems in Teleosts
por: Rønnestad, Ivar, et al.
Publicado: (2017)

Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring
por: Takeishi, Soichi, et al.
Publicado: (2015)

Dulaglutide (Trulicity)-Induced Acute Pancreatitis: A Case Report
por: Khan, Abu baker, et al.
Publicado: (2023)

Sex-Specific Associations Between Low Muscle Mass and Glucose Fluctuations in Patients With Type 2 Diabetes Mellitus
por: Shi, Xiulin, et al.
Publicado: (2022)

Exposure to Degludec During Pregnancy: A Case Report
por: Roman-Gonzalez, Alejandro, et al.
Publicado: (2019)

The Clinical Impact of Switching Basal Insulin to Insulin Degludec in Patients With Diabetes in Saudi Arabia: A Retrospective One-Group Pretest-Posttest Design Study
por: Althagafi, Abdulhamid, et al.
Publicado: (2022)

Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment
por: Kiss, István, et al.
Publicado: (2013)

Degludec: the new ultra-long insulin analogue
por: Tambascia, Marcos Antonio, et al.
Publicado: (2015)

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges
por: King, Allen B., et al.
Publicado: (2017)

Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
por: Kalra, Sanjay
Publicado: (2014)

Insulin Degludec, a Novel Ultra-Long-Acting Basal Insulin versus Insulin Glargine for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Zhou, Wenchuan, et al.
Publicado: (2019)

Stress Effects on the Mechanisms Regulating Appetite in Teleost Fish
por: Conde-Sieira, Marta, et al.
Publicado: (2018)

Appetite Regulation of TLR4-Induced Inflammatory Signaling
por: Li, Yongxiang, et al.
Publicado: (2021)

Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
por: Dardano, Angela, et al.
Publicado: (2014)

Safety and Efficacy of Long-Acting Insulins Degludec and Glargine Among Asian Patients With Type 2 Diabetes Mellitus: A Meta-Analysis
por: Kant, Ravi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pclsqsbhaq3ki774limqk2i50p